Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

Computer Hardware

Ion Beam Applications SA

Olivier Legrain

Christian Matton

Luk Herremans

Dr. Ronald Wichern

Charles Kumps

Jean-Marc Bothy

Henri de Romrée

Yves Jongen

Frédéric Nolf

Soumya Chandramouli

The leadership team at Ion Beam Applications SA has a wealth of experience in the industry. The chief executive officer and chief strategy officer both have experience working at iba, and the captain has experience working at amaris. The president has experience working at iba molecular. All of the leaders have a history of working in the industry, and they all have a different type of education. This gives them a well-rounded perspective on the industry and the company.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Ion Beam Applications SA

Board of Directors

CEO and Executive Team